Ankle Foot Orthoses for Foot Injuries
(AFOCE Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing two types of custom-fit carbon fiber leg braces to help adults who had serious lower leg injuries and still have trouble moving. The braces are designed to give extra support and make it easier to walk. Researchers will compare how well each brace works by measuring things like balance, speed, and comfort.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment PhatBrace AFO, Reaktiv AFO for foot injuries?
Research shows that ankle-foot orthoses (AFOs) can help improve balance and reduce the risk of falls in people with certain conditions, like after a stroke. Additionally, AFOs have been effective in treating severe ankle sprains, allowing most patients to return to activity without restrictions in a few months.12345
How is the PhatBrace AFO, Reaktiv AFO treatment different from other treatments for foot injuries?
The PhatBrace AFO and Reaktiv AFO are unique because they are designed to improve balance and walking ability by providing specific ankle support, which can be particularly beneficial for those with compromised balance or spasticity. Unlike standard treatments, these orthoses may offer tailored stiffness and support to enhance mobility and reduce fall risk.16789
Research Team
Jason M. Wilken, PT, PhD
Principal Investigator
University of Iowa
Eligibility Criteria
This trial is for adults aged 18-65 who have had a severe lower leg injury below the knee over two years ago, can walk at least 50 feet without support, and are experiencing mechanical pain. They must not be pregnant, require a knee stabilizing device for daily activities, or have conditions that would interfere with testing like severe brain injuries or heart conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Participants are evaluated under conditions with no device and standard of care
Treatment - Reaktiv Accommodation
Participants are accommodated to the Reaktiv AFO for evaluation
Treatment - PhatBrace Accommodation
Participants are accommodated to the PhatBrace AFO for evaluation
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- PhatBrace AFO
- Reaktiv AFO
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jason Wilken
Lead Sponsor
Minneapolis Veterans Affairs Medical Center
Collaborator
Walter Reed National Military Medical Center
Collaborator
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborator
Center for Veterans Research and Education
Collaborator
University of Delaware
Collaborator
Johns Hopkins Bloomberg School of Public Health
Collaborator